Adjusted restricted mean survival times in observational studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjusted restricted mean survival times in observational studies

Published:2019-05-22 Issue:20 Volume:38 Page:3832-3860
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Conner Sarah C.¹²^ORCID,Sullivan Lisa M.¹,Benjamin Emelia J.²³⁴,LaValley Michael P.¹,Galea Sandro³,Trinquart Ludovic¹²

Affiliation:

1. Department of Biostatistics, School of Public Health Boston University Boston Massachusetts

2. National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study Framingham Massachusetts

3. Department of Epidemiology, School of Public Health Boston University Boston Massachusetts

4. Section of Cardiovascular Medicine, Evans, Department of Medicine, School of Medicine Boston University Boston Massachusetts

Funder

National Heart, Lung, and Blood Institute

National Institute of General Medical Sciences

American Heart Association

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8206

Reference44 articles.

1. Hazard ratios in cancer clinical trials—a primer

2. Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials

3. On the Origin of Risk Relativism

5. Evaluating Public Health Interventions: 6. Modeling Ratios or Differences? Let the Data Tell Us

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia;International Journal of Cancer;2024-09-02

2. Evaluation of the proportional hazards assumption and covariate adjustment methods in comparative surgical observational studies with time-to-event endpoints;European Journal of Surgical Oncology;2024-09

3. Hazard Ratios and Alternative Effect Measures: An Applied Illustration;Pharmacoepidemiology and Drug Safety;2024-08-30

4. Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer;JAMA Network Open;2024-08-16

5. Sentinel lymph node biopsy versus observation in high‐risk cutaneous squamous cell carcinoma in immunosuppressed and immunocompetent patients: An inverse probability of treatment weighting study;Journal of the European Academy of Dermatology and Venereology;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3